Pfizer has maintained the same amount of revenues since 2010 which actually means it’s shrinking a bit (inflation) but this stock has a lot of value to offer. Their annual EPS is $2.80 and they pay out an annual dividend of $1.52 (4% yield) of which increases 16c every year. They have a healthy and steady Cash Flow of $4.20 and their shares outstanding have decreased at a 2-3% rate every year.
Pfizer is a Pharmaceutical company that develops and markets medicine for humans and animals valued at 200Bn
Pfizer is a Pharmaceutical company that develops and markets medicine for humans and animals valued at 200Bn
